TIAA CREF Investment Management’s Atara Biotherapeutics ATRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $3.57M | Buy |
3,591
+365
| +11% | +$363K | ﹤0.01% | 1655 |
|
|
2018
Q4 | $2.8M | Sell |
3,226
-65
| -2% | -$56.5K | ﹤0.01% | 1750 |
|
|
2018
Q3 | $3.4M | Sell |
3,291
-284
| -8% | -$294K | ﹤0.01% | 1838 |
|
|
2018
Q2 | $3.29M | Buy |
3,575
+622
| +21% | +$572K | ﹤0.01% | 1895 |
|
|
2018
Q1 | $2.88M | Buy |
2,953
+474
| +19% | +$462K | ﹤0.01% | 1901 |
|
|
2017
Q4 | $1.12M | Sell |
2,479
-73
| -3% | -$33K | ﹤0.01% | 2411 |
|
|
2017
Q3 | $1.06M | Sell |
2,552
-164
| -6% | -$67.9K | ﹤0.01% | 2488 |
|
|
2017
Q2 | $950K | Buy |
2,716
+187
| +7% | +$65.4K | ﹤0.01% | 2573 |
|
|
2017
Q1 | $1.3M | Sell |
2,529
-198
| -7% | -$102K | ﹤0.01% | 2388 |
|
|
2016
Q4 | $968K | Sell |
2,727
-48
| -2% | -$17K | ﹤0.01% | 2558 |
|
|
2016
Q3 | $1.48K | Sell |
2,775
-90
| -3% | -$48 | ﹤0.01% | 2339 |
|
|
2016
Q2 | $1.61M | Buy |
2,865
+787
| +38% | +$443K | ﹤0.01% | 2255 |
|
|
2016
Q1 | $989K | Sell |
2,078
-873
| -30% | -$415K | ﹤0.01% | 2478 |
|
|
2015
Q4 | $1.95M | Sell |
2,951
-59
| -2% | -$39K | ﹤0.01% | 2173 |
|
|
2015
Q3 | $2.37M | Buy |
3,010
+400
| +15% | +$314K | ﹤0.01% | 2042 |
|
|
2015
Q2 | $3.44M | Buy |
2,610
+1,845
| +241% | +$2.43M | ﹤0.01% | 1946 |
|
|
2015
Q1 | $795K | Buy |
765
+650
| +565% | +$675K | ﹤0.01% | 2741 |
|
|
2014
Q4 | $77K | Buy |
+115
| New | +$77K | ﹤0.01% | 3125 |
|